Skip to content
10-Q/A

Quarterly Report

SALIX PHARMACEUTICALS LTD

0001193125-15-073244

← back to feed
Filed
Mar 2, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 4, 2014 63.69M sh
Shares Diluted Q2 2014 · Jun 30, 2014 75.45M sh
Shares Diluted Q2 2014 · Jun 30, 2014 63.38M sh
Shares Diluted Q2 2014 · Jun 30, 2013 64.91M sh
Shares Diluted Q2 2014 · Jun 30, 2013 64.25M sh
Capex Q2 2014 · Jun 30, 2014 $10.27M
Capex Q2 2014 · Jun 30, 2013 $2.76M
Cash And Equivalents Q2 2014 · Jun 30, 2014 $435.26M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $1.16B
Cash And Equivalents Q2 2014 · Jun 30, 2013 $817.98M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $751.01M
Stockholders Equity restated Q2 2014 · Jun 30, 2014 $729.48M
Stockholders Equity restated Q2 2014 · Dec 31, 2013 $728.64M
Current Liabilities restated Q2 2014 · Jun 30, 2014 $941.3M
Current Liabilities restated Q2 2014 · Dec 31, 2013 $417.24M
Current Assets restated Q2 2014 · Jun 30, 2014 $1.42B
Current Assets restated Q2 2014 · Dec 31, 2013 $2.28B
Total Assets restated Q2 2014 · Jun 30, 2014 $4.8B
Total Assets restated Q2 2014 · Dec 31, 2013 $2.93B
Eps Diluted restated Q2 2014 · Jun 30, 2014 $0.01
Eps Diluted restated Q2 2014 · Jun 30, 2014 −$0.54
Eps Diluted Q2 2014 · Jun 30, 2013 $0.32
Eps Diluted Q2 2014 · Jun 30, 2013 $0.68
Eps Basic restated Q2 2014 · Jun 30, 2014 $0.01
Eps Basic restated Q2 2014 · Jun 30, 2014 −$0.54
Eps Basic Q2 2014 · Jun 30, 2013 $0.34
Eps Basic Q2 2014 · Jun 30, 2013 $0.71
Sga Expense restated Q2 2014 · Jun 30, 2014 $138.36M
Sga Expense restated Q2 2014 · Jun 30, 2014 $345.46M
Sga Expense restated Q2 2014 · Jun 30, 2013 $90.44M
Sga Expense restated Q2 2014 · Jun 30, 2013 $175.43M
Rd Expense restated Q2 2014 · Jun 30, 2014 $25.58M
Rd Expense restated Q2 2014 · Jun 30, 2014 $66.8M
Rd Expense restated Q2 2014 · Jun 30, 2013 $35.11M
Rd Expense restated Q2 2014 · Jun 30, 2013 $56.71M
Net Income restated Q2 2014 · Jun 30, 2014 $418K
Net Income restated Q2 2014 · Jun 30, 2014 −$34.16M
Net Income Q2 2014 · Jun 30, 2013 $21M
Net Income Q2 2014 · Jun 30, 2013 $43.44M
Operating Income restated Q2 2014 · Jun 30, 2014 $42.98M
Operating Income restated Q2 2014 · Jun 30, 2014 $22.76M
Operating Income Q2 2014 · Jun 30, 2013 $50.14M
Operating Income Q2 2014 · Jun 30, 2013 $99.42M
Cost Of Revenue restated Q2 2014 · Jun 30, 2014 $104.57M
Cost Of Revenue restated Q2 2014 · Jun 30, 2014 $221.51M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $46.49M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $79.56M
Revenue restated Q2 2014 · Jun 30, 2014 $375.54M
Revenue restated Q2 2014 · Jun 30, 2014 $778.52M
Revenue Q2 2014 · Jun 30, 2013 $235.44M
Revenue Q2 2014 · Jun 30, 2013 $438.04M